Clinical Trial Update: Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating Tongjiang Granule for nonerosive reflux disease overlapping epigastric pain syndrome, currently in Phase 1/Phase 2 with unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dysphonia
• Gastroesophageal Reflux Disease

Drugs mentioned

• Tongjiang Granule

Snippet

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences | Conditions: Gastroesophageal Reflux, Functional Dysphonia | Phase 1, Phase 2 | Status: UNKNOWN